Adaptive Biotechnologies Corporation (ADPT)
NASDAQ: ADPT · Real-Time Price · USD
13.75
+0.04 (0.29%)
Nov 18, 2025, 4:00 PM EST - Market closed
Adaptive Biotechnologies Stock Forecast
Stock Price Forecast
The 10 analysts that cover Adaptive Biotechnologies stock have a consensus rating of "Strong Buy" and an average price target of $16.6, which forecasts a 20.73% increase in the stock price over the next year. The lowest target is $10 and the highest is $21.
Price Target: $16.6 (+20.73%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Adaptive Biotechnologies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 4 | 5 | 5 | 5 |
| Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 7 | 7 | 8 | 9 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Morgan Stanley | Morgan Stanley | Hold Maintains $11 → $16 | Hold | Maintains | $11 → $16 | +16.36% | Nov 11, 2025 |
| BTIG | BTIG | Strong Buy Maintains $19 → $21 | Strong Buy | Maintains | $19 → $21 | +52.73% | Nov 6, 2025 |
| JP Morgan | JP Morgan | Buy Maintains $17 → $20 | Buy | Maintains | $17 → $20 | +45.45% | Nov 6, 2025 |
| BTIG | BTIG | Strong Buy Maintains $14 → $19 | Strong Buy | Maintains | $14 → $19 | +38.18% | Oct 22, 2025 |
| Piper Sandler | Piper Sandler | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | +45.45% | Oct 15, 2025 |
Financial Forecast
Revenue This Year
244.15M
from 178.96M
Increased by 36.43%
Revenue Next Year
274.20M
from 244.15M
Increased by 12.31%
EPS This Year
-0.69
from -1.08
EPS Next Year
-0.62
from -0.69
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 270.6M | 293.0M | |||
| Avg | 244.2M | 274.2M | |||
| Low | 219.6M | 247.4M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 51.2% | 20.0% | |||
| Avg | 36.4% | 12.3% | |||
| Low | 22.7% | 1.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.58 | -0.58 | |||
| Avg | -0.69 | -0.62 | |||
| Low | -0.78 | -0.74 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.